NFKB1 and Hyperglycemia: Hyperglycemia triggers immune cells to release inflammatory mediators (including TNF-α, IL-1β, IL-6, NF-κB, TGF-β, and adhesion molecules), which further contribute to β-cell dysfunction, insulin resistance, and progression of complications such as vascular damage, neuropathy, and CVD cell loss [41].